Biomimetic Leaf Device for Cell Viability

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Current cell delivery systems lack efficient methods for maintaining cell viability and facilitating the distribution of soluble molecules produced by cells, particularly due to inadequate vascularization, which leads to cell death and reduced therapeutic efficacy in treating diseases like chronic wounds and diabetes.

Innovation Solution

A biomimetic, leaf-inspired device with interconnected channels is designed for 3D cell culture, using cellulose nanofibrils and alginate hydrogels, allowing for vascularization and perfusion, enabling the delivery of cells and soluble molecules through a perfusion system or direct implantation.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Ease of operation

If cells are injected into the host's blood system for delivery, then cell therapy can be administered, but the cells quickly end up in the liver or lungs where they are killed by the immune system, reducing efficacy

Engineering Contradiction:
Improvecell deliveryVSAvoidcell viability
Core Design Contradiction:
Ease of operationVSReliability

Solution Approach 1:

The patent uses an alginate bead as an intermediary carrier that protects cells from immune system attack in the liver and lungs while enabling controlled release. The bead acts as a protective medium that allows cells to survive circulation and reach the target tissue alive, resolving the contradiction between ease of delivery and cell viability.

Inventive Principle:
Principle #24Intermediary (Mediator)

Solution Approach 2:

The alginate bead forms a flexible protective shell around the cells that maintains cell integrity during circulation. This shell protects against immune-mediated cell death while allowing necessary exchanges, thereby improving both delivery capability and cell survival rate.

Inventive Principle:
Principle #30Flexible shells and thin films

2Reliability

If cells are immobilized in hydrogels, then cell viability can be maintained, but the distance from the surrounding capsule has to be less than 200-300 micrometers to avoid necrosis, limiting device size

Engineering Contradiction:
Improvecell viabilityVSAvoiddevice size
Core Design Contradiction:
ReliabilityVSVolume of moving object

Solution Approach 1:

The patent segments the device into multiple alginate beads distributed throughout the hydrogel matrix. Each bead acts as an independent vascular unit with its own diffusion pathways, allowing the overall device to be much larger while maintaining cell viability within each segmented unit. This resolves the contradiction by enabling larger device volume without compromising cell survival.

Inventive Principle:
Principle #1Segmentation

Solution Approach 2:

The alginate beads create a porous vascular network within the hydrogel that facilitates nutrient and oxygen diffusion over longer distances. The porous structure formed by the beads and their interconnections allows cells to survive at greater distances from the capsule by improving mass transport, thereby enabling larger device sizes while maintaining viability.

Inventive Principle:
Principle #31Porous materials

3Reliability

If vascularization is introduced to improve cell survival, then nutrients and oxygen delivery is enhanced, but the device structure becomes more complex

Engineering Contradiction:
Improvecell viabilityVSAvoidvascular structure
Core Design Contradiction:
ReliabilityVSDevice complexity

Solution Approach 1:

The alginate beads automatically form a vascular network through their own structural properties and the natural diffusion processes. The beads self-assemble into interconnected pathways that provide vascularization without requiring external scaffolding or complex fabrication processes. This self-organizing behavior resolves the contradiction by achieving vascularization while maintaining relatively simple device structure.

Inventive Principle:
Principle #25Self-service

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

The device improves cell viability by providing nutrients and oxygen, enhances the distribution of therapeutic molecules, and allows for effective treatment of diseases by maintaining cell health and functionality.

Implementation Method 1

They have a hydrophilic surface, in aspects, and therefore bind water on their surfaces forming hydrogels already at low solid content (1-2%)

Methodology Applied
Scientific EffectHydrophilic binding: Absorption (physical)

Implementation Method 2

CNF can be combined with alginates and after crosslinking will form robust hydrogels

Methodology Applied
Scientific EffectCrosslinking: Chemical Bonding

Implementation Method 3

Cells produce soluble ligands or other extracellular components which can diffuse out and be used for communication with other cells

Methodology Applied
Scientific EffectDiffusion: Diffusion

Implementation Method 4

the main channel and branches are interconnected and enable native vascularization... The channel can be connected to a perfusion system

Methodology Applied
Scientific EffectPerfusion: Convection

Data Source

PatentUS20220354993A1Biomimetic three-dimensional device for delivery of therapeutic cells and method of making device
Publication Date: 2022.11.10 GATENHOLM PAUL
  • US20220354993A1 patent drawing
  • US20220354993A1 patent drawing
  • US20220354993A1 patent drawing

AI summary

A cell delivery device and a method of producing a three dimensional device which is vascularized when implanted or topologically applied to human or animal body. Cell laden hydrogel (cells mixed with hydrogel) is casted or injected or 3D bioprinted in a leaf-like form, which contains removable parts (templates). After crosslinking, the templates are removed and the channel for vascularization is created. The device is ready for use in vitro or in vivo.